Pulmonary Arterial Hypertension in Hyperthyroidism: Age, Ethnic, and Gender Disparities
DOI:
https://doi.org/10.12970/2310-9874.2023.11.01Keywords:
PAH, hyperthyoidism, autoimmune, disparity, pathophysiology, Graves’ disease, multinodular, goiterAbstract
Objective: Pulmonary arterial hypertension (PAH) affects 2.6% of adults and 36% of people with chronic obstructive pulmonary disease (COPD). Several case reports and small case series suggested a hyperthyroidism-PAH association.
Design: Retrospective chart review.
Methods: We undertook a retrospective chart review (1982–2018) to assess PAH prevalence in a multi-ethnic convenience sample of hyperthyroid adults with multiple etiologies. We calculated associations of pulmonary artery maximum systolic pressure (PSAPmax) with subject age, and maximum serum triiodothyronine (T3) and thyroxine (T4), free T3, and T4, minimum serum thyroid-stimulating hormone (TSH), and thyroid antibody titers, comparing PAH prevalence and the odds of being undiagnosed as to hyperthyroidism etiology by gender and ethnicity/race.
Results: We found a high prevalence of PAH in hyperthyroid people, like that reported for people with COPD. We found no significant association between PSAPmax and any thyroid function test or thyroid antibody titer. As reported more recently in the general population, PSAPmax significantly correlated with age in hyperthyroid people. There was no significant disparity in the prevalence of PAH among White, non-Hispanic Black, and Latinx hyperthyroid people or between genders. The percentage of patients whose hyperthyroidism etiology was undiagnosed was high with significant disparity only between non-Hispanic Black and White people and between men and women. PAH was common in hyperthyroid subjects with any hyperthyroidism etiology.
Conclusions: 2D-echocardiography should be performed in all hyperthyroid people because PAH is common, especially in older people because of their co-morbidities and poorer prognoses. Further research is needed regarding demographic disparities in being undiagnosed as to hyperthyroidism etiology.
Principal Verdicts/Significance Statement: We reconfirmed the high PAH incidence in hyperthyroidism, previously reported, but profoundly under-recognized by physicians, to patients’ detriment. Further, we found that the shift in the general PAH population from younger to older individuals is mirrored in hyperthyroid people with PAH. This is concerning because older people have more co-morbidities and worse prognoses, necessitating early, effective intervention. PAH was present with diverse hyperthyroidism etiologies, suggesting that it is multicausal, resulting from autoimmunity, thyroid hormone excess, and goitrous upper airway obstruction and should be considered, regardless of etiology. Our observations that many subjects had no established hyperthyroidism etiology and that males and Blacks were likelier to be undiagnosed are concerning, warranting further study.
References
Baby, AP, Inoue T, Cohen R, Mirrer B, Rosenzweig B, Bahtiyar G, Sacerdote A. Improvement in pulmonary hypertension and closure of a patent foramen ovale with treatment of hyperthyroidism in a patient with Graves’ disease. J Autoimmune Dis Rheumat 2014; 2: 71-73. https://doi.org/10.12970/2310-9874.2014.02.03.1 DOI: https://doi.org/10.12970/2310-9874.2014.02.03.1
Suk JH, Cho KI, Lee SH, Lee HG, Kim SM, Kim TI, Kim MK, Shong YK. Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves' disease: before and after antithyroid treatment. J Endocrinol Invest 2011; 34(8): e229-34.
Badesch DB, Wynne KM, Bonvallet S, Voelkel NF, Ridgway C, Groves BM. Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann Intern Med 1993; 119(1): 44-6. https://doi.org/10.7326/0003-4819-119-1-199307010-00008 DOI: https://doi.org/10.7326/0003-4819-119-1-199307010-00008
Curnock AL, Dweik RA, Higgins BH, Saadi HF, Arroliga AC. High prevalence of hypothyroidism in patients with primary pulmonary hypertension. Am J Med Sci 1999; 318(5): 289-92. https://doi.org/10.1016/S0002-9629(15)40640-8 DOI: https://doi.org/10.1016/S0002-9629(15)40640-8
Chu JW, Kao PN, Faul JL, Doyle RL. High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 2002; 122(5): 1668-73. https://doi.org/10.1378/chest.122.5.1668 DOI: https://doi.org/10.1378/chest.122.5.1668
Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 2005; 26(6): 1110-8. https://doi.org/10.1183/09031936.05.00045705 DOI: https://doi.org/10.1183/09031936.05.00045705
Fenteany G, Inoue T, Bahtiyar G, Fishman S, Sacerdote AS. Pulmonary arterial hypertension in patients with hyperthyroid Graves’ disease and toxic multinodular goiter. Endoc Rev 2017; Poster Number SUN 221 Sunday April 2, 2017 https://endo.confex.com/endo/2017endo/meetingapp.cgi/Paper/29235.
Marvisi M, Balzarini L, Mancini C, Mouzakiti P. Thyroid gland and pulmonary hypertension. What's the link? Panminerva Med 2013; 55(1): 93-7.
Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev 1983 Fall; 4(4): 378-88. https://doi.org/10.1210/edrv-4-4-378 DOI: https://doi.org/10.1210/edrv-4-4-378
Marvisi M, Ajolfi C, Civardi G, Delsignore R. Distiroidismi e ipertensione polmonare [Thyroid dysfunction and pulmonary hypertension]. Recenti Prog Med 2004; 95(9): 443-6.
Hoeper MM, Simon R Gibbs J. The changing landscape of pulmonary arterial hypertension and implications for patient care. Eur Respir Rev 2014; 23(134): 450-7. https://doi.org/10.1183/09059180.00007814 DOI: https://doi.org/10.1183/09059180.00007814
Al-Naamani N, Paulus JK, Roberts KE, Pauciulo MW, Lutz K, Nichols WC, Kawut SM. Racial and ethnic differences in pulmonary arterial hypertension. Pulm Circ 2017; 7(4): 793-796. https://doi.org/10.1177/2045893217732213 DOI: https://doi.org/10.1177/2045893217732213
Li JH, Safford RE, Aduen JF, Heckman MG, Crook JE, Burger CD. Pulmonary hypertension and thyroid disease. Chest 2007; 132(3): 793-7. https://doi.org/10.1378/chest.07-0366 DOI: https://doi.org/10.1378/chest.07-0366
Al Husseini A, Bagnato G, Farkas L, Gomez-Arroyo J, Farkas D, Mizuno S, Kraskauskas D, Abbate A, Van Tassel B, Voelkel NF, Bogaard HJ. Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats. Eur Respir J 2013; 41(1): 104-14. https://doi.org/10.1183/09031936.00196511 DOI: https://doi.org/10.1183/09031936.00196511
Naiboglu B, Deveci S, Duman D, Kaya KS, Toros S, Kinis V, Sürmeli M, Deveci I, Gokceer T. Effect of upper airway obstruction on pulmonary arterial pressure in children. Int J Pediatr Otorhinolaryngol 2008; 72(9): 1425-9. https://doi.org/10.1016/j.ijporl.2008.06.005 DOI: https://doi.org/10.1016/j.ijporl.2008.06.005
Chadha C, Pritzker M, Mariash CN. Effect of epoprostenol on the thyroid gland: enlargement and secretion of thyroid hormone. Endocr Pract 2009; 15(2): 116-21. https://doi.org/10.4158/EP.15.2.116 DOI: https://doi.org/10.4158/EP.15.2.116
Batton KA, Austin CO, Bruno KA, Burger CD, Shapiro BP, Fairweather D. Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease. Biol Sex Differ 2018; 9(1): 15. https://doi.org/10.1186/s13293-018-0176-8 DOI: https://doi.org/10.1186/s13293-018-0176-8
Samulowitz A, Gremyr I, Eriksson E, Hensing G. "Brave Men" and "emotional women": A theory-guided literature review on gender bias in health care and gendered norms towards patients with chronic pain. Pain Res Manag 2018; 2018: 6358624. https://doi.org/10.1155/2018/6358624 DOI: https://doi.org/10.1155/2018/6358624
Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost 2020; 5(1): 51-54. https://doi.org/10.1002/rth2.12468 DOI: https://doi.org/10.1002/rth2.12468
Liu G, Kong L, Baweja R, Ba D, Saunders EFH. Gender disparity in bipolar disorder diagnosis in the United States: A retrospective analysis of the 2005-2017 MarketScan Commercial Claims database. Bipolar Disord 2022; 24(1): 48-58. https://doi.org/10.1111/bdi.13082 DOI: https://doi.org/10.1111/bdi.13082
Gazzana ML, Souza JJ, Okoshi MP, Okoshi K. Prospective echocardiographic evaluation of the right ventricle and pulmonary arterial pressure in hyperthyroid patients. Heart Lung Circ 2019; 28(8): 1190-1196. https://doi.org/10.1016/j.hlc.2018.06.1055 DOI: https://doi.org/10.1016/j.hlc.2018.06.1055
Sacerdote A. Spectrum of thyroid disorders found in post-Chernobyl Polish emigres at a Brooklyn, NY clinic. J Invest Med. Presented at The Clinical Research Meeting May 5-8, 1995; 43(2) (Supp 2): 226A.
Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004; 30(4): 369-84. https://doi.org/10.1016/j.ctrv.2003.12.003 DOI: https://doi.org/10.1016/j.ctrv.2003.12.003
Pacini F, Vorontsova T, Molinaro E, Shavrova E, Agate L, Kuchinskaya E, Elisei R, Demidchik EP, Pinchera A. Thyroid consequences of the Chernobyl nuclear accident. Acta Paediatr Suppl 1999; 88(433): 23-7. https://doi.org/10.1111/j.1651-2227.1999.tb14399.x DOI: https://doi.org/10.1111/j.1651-2227.1999.tb14399.x
Kirkpatrick EC. Pulmonary hypertension as a complication of pediatric cancer. Glob Pediatr Health 2021; 8: 2333794X211009094. https://doi.org/10.1177/2333794X211009094 DOI: https://doi.org/10.1177/2333794X211009094
Kramer MR, Estenne M, Berkman N, Antoine M, de Francquen P, Lipski A, Jacobovitz D, Lafair J. Radiation-induced pulmonary veno-occlusive disease. Chest 1993; 104(4): 1282-4. https://doi.org/10.1378/chest.104.4.1282 DOI: https://doi.org/10.1378/chest.104.4.1282
Manes A, Palazzini M, Dardi F, D'Adamo A, Rinaldi A, Galiè N. Genere femminile e ipertensione arteriosa polmonare: una relazione complessa [Female gender and pulmonary arterial hypertension: a complex relationship]. G Ital Cardiol (Rome) 2012; 13(6): 448-60.
